Fundraising Fox
Sera Prognostics
NASDAQ: SERASalt Lake City, US · Delaware corporation · 8 known investors
Find your way into Sera Prognostics
Sign up to see every warm intro you have to Sera Prognostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sera Prognostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.
Founders & leadership
DF
Douglas FisherExecutive
JM
Jay MoyesChief Financial Officer2020–2023Jay Moyes is Executive Officer of Sera Prognostics, which develops diagnostic blood tests and data platforms for pregnancy risk assessment. He brings over three decades of management experience at industry-leading companies during their growth and transition to public markets.
AA
Andrew A. SauterCFO2010–2020Andrew A. Sauter is Chief Executive Officer of Sera Prognostics, a women's health diagnostics company. He previously held finance and strategic leadership roles at venture-backed and public life science companies, including experience in clinical development, financing, reimbursement strategy, and M&A.
ZL
Zhenya LindgardtCEO and PresidentZhenya Lindgardt previously held leadership roles at the Commons Project Foundation as CEO and at Uber as VP of Platform and Customer Engagement, and was a Senior Partner and Managing Director at Boston Consulting Group in New York. He holds a BA in Business Administration from the University of Southern California and an MBA from Harvard Business School.
Board
MM
Mansoor MirzaBoard director
RM
Ryan M. TrimbleBoard director
JS
DB
KK
MM
Michael MinahanBoard director
JP
Investors · 8
aMoonlisted by aMoonRa'anana
How we know: aMoon's portfolio page · a partner's Signal profile · Not right? Tell us
Excelestar Ventureslisted by Excelestar VenturesAndover
How we know: Excelestar Ventures's portfolio page · Not right? Tell us
OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
UpStart Ventureslisted by UpStart VenturesSalt Lake Cityvia Dennis Farrar · board
How we know: UpStart Ventures's portfolio page · board seat on SEC Form D · Not right? Tell us
Vivo Capitallisted by Vivo CapitalPalo Alto · $10M – $50Mvia Joseph Siletto · board
How we know: Vivo Capital's portfolio page · the S-1 prospectus · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
Catalyst Health VenturesreportedBoston · $1M – $3M
How we know: funding news · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15M
How we know: the S-1 prospectus · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$207.4M disclosed across 8 rounds · 2013–2021
▶$100.3MraisedMay 2021 · 16 investors · Other Health CareRule 506(b)
▶$100.3MraisedMay 2021 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mansoor MirzaDirector
- Marcus WilsonDirector
- Ryan M. TrimbleDirector
- Joseph SilettoDirector
- Dennis B. FarrarDirector
- Douglas FisherExecutive Officer
- Kim KamdarDirector
- Michael MinahanDirector
- Jay MoyesExecutive Officer
- Joshua PhillipsDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Elizabeth CanisDirector
- Charles KennedyDirector
- Offering amount
- $100.3M
- Amount sold
- $100.3M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$51.8MraisedFeb 2020 · 28 investors · Other Health CareRule 506(b)
▶$51.8MraisedFeb 2020 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas FisherExecutive Officer
- Dennis B. FarrarDirector
- Andrew A. SauterExecutive Officer
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Michael MinahanDirector
- Ryan M. TrimbleDirector
- Mansoor Raza MirzaDirector
- Charles D. KennedyDirector
- Arnold Oronsky, Ph.D.Director
- Kim KamdarDirector
- Offering amount
- $53.5M
- Amount sold
- $51.8M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedMar 2019 · 1 investors · Other Health CareRule 506(b)
▶$6.4MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis B. FarrarDirector
- Ryan M. TrimbleDirector
- Joshua PhillipsDirector
- Mansoor Raza MirzaDirector
- Douglas FisherExecutive Officer
- Arnold Oronsky, Ph.D.Director
- Andrew A. SauterExecutive Officer
- Michael MinahanDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Kim KamdarDirector
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.6MraisedDec 2018 · 12 investors · Other Health CareRule 506(b)
▶$7.6MraisedDec 2018 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arnold Oronsky, Ph.D.Director
- Michael MinahanDirector
- Douglas FisherExecutive Officer
- Joshua PhillipsDirector
- Mansoor Raza MirzaDirector
- Dennis B. FarrarDirector
- Andrew A. SauterExecutive Officer
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $7.6M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.7MraisedJan 2017 · 5 investors · Other Health CareRule 506(b)
▶$22.7MraisedJan 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Michael MinahanDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Douglas FisherExecutive Officer
- Andrew A. SauterExecutive Officer
- Dennis B. FarrarDirector
- Arnold Oronsky, Ph.D.Director
- Mansoor Raza MirzaDirector
- Offering amount
- $45M
- Amount sold
- $22.7M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2014 · 15 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2014 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis B. FarrarDirector
- Douglas FisherDirector
- Ryan M. TrimbleDirector
- Andrew A. SauterExecutive Officer
- Joshua PhillipsDirector
- Kim KamdarDirector
- Richard L. NovakDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedJun 2014 · 15 investors · Other Health CareRule 506(b)
▶$9.2MraisedJun 2014 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas FisherDirector
- Kim KamdarDirector
- Richard L. NovakDirector
- Andrew A. SauterExecutive Officer
- Dennis B. FarrarDirector
- Ryan M. TrimbleDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedMar 2014 · 11 investors · Other Health CareRule 506(b)
▶$4.5MraisedMar 2014 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew A. SauterExecutive Officer
- Douglas FisherDirector
- Richard L. NovakDirector
- Joshua PhillipsDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Dennis B. FarrarDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$488.1Mvaluation at IPOJul 2021 · $16.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 6
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies working in the same space as Sera Prognostics.
Frequently asked questions
- What does Sera Prognostics do?
- Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.
- Who are Sera Prognostics's investors?
- Sera Prognostics's investors include aMoon, Excelestar Ventures, Intermountain Health, OUP (Osage University Partners), UpStart Ventures, Vivo Capital, Catalyst Health Ventures, Domain Associates.
- How much funding has Sera Prognostics raised?
- Sera Prognostics has disclosed $207.4M raised across 8 rounds.
- Where is Sera Prognostics headquartered?
- Sera Prognostics is headquartered in Salt Lake City, US.